Shimiao WANG

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 11,608,335
- Issue date Mar 21, 2023
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
- Patent number 11,566,015
- Issue date Jan 31, 2023
- CRINETICS PHARMACEUTICALS, INC.
- Sangdon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nonpeptide somatostatin type 5 receptor agonists and uses thereof
- Patent number 11,479,540
- Issue date Oct 25, 2022
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 11,414,397
- Issue date Aug 16, 2022
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 11,028,068
- Issue date Jun 8, 2021
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
- Patent number 10,981,894
- Issue date Apr 20, 2021
- CRINETICS PHARMACEUTICALS, INC.
- Sangdon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 10,875,839
- Issue date Dec 29, 2020
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
- Patent number 10,604,507
- Issue date Mar 31, 2020
- CRINETICS PHARMACEUTICALS, INC.
- Sangdon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 10,597,377
- Issue date Mar 24, 2020
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
- Patent number 10,562,884
- Issue date Feb 18, 2020
- CRINETICS PHARMACEUTICALS, INC.
- Sangdon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 10,351,547
- Issue date Jul 16, 2019
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 9,902,703
- Issue date Feb 27, 2018
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Somatostatin modulators and uses thereof
- Patent number 9,896,432
- Issue date Feb 20, 2018
- CRINETICS PHARMACEUTICALS, INC.
- Jian Zhao
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20250136573
- Publication date May 1, 2025
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20240300920
- Publication date Sep 12, 2024
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20240109866
- Publication date Apr 4, 2024
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20230159532
- Publication date May 25, 2023
- Crinetics Pharmaceuticals, Inc.
- Joseph PONTILLO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20220380337
- Publication date Dec 1, 2022
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20220144802
- Publication date May 12, 2022
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20210238164
- Publication date Aug 5, 2021
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20210171492
- Publication date Jun 10, 2021
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20210047287
- Publication date Feb 18, 2021
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20210040087
- Publication date Feb 11, 2021
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20210002254
- Publication date Jan 7, 2021
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATASTATIN MODULATORS AND USES THEREOF
- Publication number 20200207737
- Publication date Jul 2, 2020
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20200190053
- Publication date Jun 18, 2020
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20200010452
- Publication date Jan 9, 2020
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20190382367
- Publication date Dec 19, 2019
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
- Publication number 20190367481
- Publication date Dec 5, 2019
- Crinetics Pharmaceuticals, Inc.
- Sangdon HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20190002431
- Publication date Jan 3, 2019
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20180016252
- Publication date Jan 18, 2018
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOMATOSTATIN MODULATORS AND USES THEREOF
- Publication number 20170001966
- Publication date Jan 5, 2017
- Crinetics Pharmaceuticals, Inc.
- Jian ZHAO
- C07 - ORGANIC CHEMISTRY

Shimiao WANG

Person

Patents Grantslast 30 patents

Somatostatin modulators and uses thereof

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Nonpeptide somatostatin type 5 receptor agonists and uses thereof

Somatostatin modulators and uses thereof

Somatostatin modulators and uses thereof

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Somatostatin modulators and uses thereof

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Somatostatin modulators and uses thereof

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Somatostatin modulators and uses thereof

Somatostatin modulators and uses thereof

Somatostatin modulators and uses thereof

Patents Applicationslast 30 patents

NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

SOMATASTATIN MODULATORS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF

SOMATOSTATIN MODULATORS AND USES THEREOF